Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Mulati Rexiati is a pioneering urological surgeon whose work is redefining the boundaries of surgical care through telemedicine. His primary research focuses on the reliability and safety of telesurgery, with a specific emphasis on robotic-assisted urological procedures. Dr. Rexiati’s most significant contribution is leading the first multicentre, non-inferiority randomised controlled trial comparing urological telesurgery to standard local surgery. This landmark study, published in 2026, demonstrated that remote robotic operations are as reliable as in-person procedures, a finding with profound implications for expanding access to specialised surgical care in underserved regions. With 4 citations in its early publication stage, this work is already shaping clinical protocols and inspiring further investigation into tele-robotic applications. Dr. Rexiati’s rigorous trial design, involving five hospitals across China, underscores his commitment to evidence-based innovation. His achievements position him as a key figure in the future of surgical practice, bridging the gap between advanced technology and patient-centred outcomes.